Warfarin Sodium
Product Images NDC 70934-912

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 912 30 Master Bottle Label Approval Rev A 10 21)

Label (70934 912 30 Master Bottle Label Approval   Rev A 10 21)
Warfarin Sodium Tablets, USP 2 mg label showing 30 tablets per package. The label includes NDC 70934-912-30 and instructions such as Rx only, storage conditions (20°-25°C), and a warning that the product is a highly potent anticoagulant. The labeler is Denton Pharma, Inc. DBA Northwind Pharmaceuticals.*
FDA Label Image

Warfarin Structural Formula (Image 1)

Warfarin Structural Formula (Image 1)
Chemical structure of Warfarin Sodium, showing the molecular arrangement including aromatic rings, a ketone group, and sodium salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.